Your fact-checks will appear here
Nonprofit organization
Bill Gates has made personal investments aimed at Alzheimer’s research totaling about $100 million — a $50 million check to the Dementia Discovery Fund (DDF) and roughly $50 million pledged for start‑...
Bacopa monnieri can alter drug metabolism via inhibition of several cytochrome P450 enzymes (notably CYP3A4, CYP2C9 and CYP2C19) and may therefore raise or lower blood levels of drugs processed by tho...
has a modest but consistent randomized clinical-trial footprint showing small improvements on some memory and attention tests across multiple placebo‑controlled trials and meta‑analyses . The current ...
Yes — Bill Gates (through Gates Ventures and personal initiatives) and allied philanthropic investments have funded biomarker research and programs that support clinical trials in Alzheimer’s disease,...
Clinical research testing honey or cinnamon specifically for cognitive decline in adults is extremely limited: systematic reviews identify two small human cinnamon studies (one positive in adolescents...
Bill Gates has put at least $100 million of personal money into Alzheimer’s-related efforts: a $50 million pledge to the UK-based Dementia Discovery Fund in 2017 plus another $50 million he said would...
Available clinical reviews and trials find no clear evidence that stopping Bacopa monnieri causes a defined withdrawal syndrome or persistent cognitive decline; clinical reports describe it as general...
The (DxA), run by the , has directly funded scores of projects—ranging from blood-based amyloid assays and retinal scans to and biomarker studies—and has moved several into late-stage validation or co...
Randomized trials that reported in older adults with mild cognitive impairment () most commonly used daily phosphatidylserine (PS) doses on the order of ~300 mg, typically given as three 100 mg doses,...
Randomized controlled trials specifically testing honey for mild cognitive impairment (MCI) or Alzheimer’s disease do not exist in the published literature . Cinnamon has been evaluated in a tiny clin...
Bill Gates personally committed roughly $100 million to Alzheimer’s and dementia efforts beginning in 2017, and the bulk of that money has gone to drug discovery, diagnostics and venture-style investm...
Venture capital is often absent where commercial returns are unclear, and the reporting shows that in dementia research those gaps most frequently align with social-science, prevention/implementation ...
Clinical trials from 2023–2025 provide some evidence that citicoline, Bacopa monnieri, lion’s mane, and omega‑3s can produce modest cognitive or mood benefits in specific populations, but results are ...
has committed personal and philanthropic capital to multiple Alzheimer’s initiatives that target early detection, diagnostics, data sharing and therapeutic pipelines, including multi‑million‑dollar in...
has directed a mix of personal and philanthropic capital into Alzheimer’s research across venture-style funds, initiatives, data-sharing efforts and targeted grants—most prominently a stake in the , a...
has invested heavily in Alzheimer’s research—through personal investments, grant funding, and initiatives like and partnerships with drug-discovery consortia—but the reporting provided does not show h...
Systematic reviews and at least one systematic review/meta-analysis-style paper exist for : a systematic review of 40 studies concluded most preclinical work shows cognitive benefit and a meta-analysi...
Three small and a handful of pilot RCTs have tested (Hericium erinaceus) for cognitive outcomes; results are mixed—some trials report modest benefits on specific measures or activities of daily living...
A systematic review identified five randomized controlled trials (RCTs) that tested in people with Alzheimer’s disease (AD) or mild cognitive impairment () attributable to AD, with wide variation in f...
A small, investigator‑initiated Phase I ALS safety trial and at least one registered Phase IIa trial for early‑stage Alzheimer’s disease / mild cognitive impairment are recorded in the public literatu...